PRECEPT

PRECEPT (PRostatE CancEr Prognosis and Treatment)

PRECEPT is one of the three projects within the Prostate Cancer Research Alliance (PCRA), a three-year program which is jointly funded by the Australian Government and the Movember Foundation.

This research project brings together a multi-institutional, trans-disciplinary and international team, who, through their collective experience and expertise, are uniquely placed to make significant improvements to the outcomes of men with localised prostate cancer within the next 5 to 7 years by:

  1. generating better methods to identify patients with lethal prostate cancer early in their natural history;
  2. developing new treatment strategies for high risk disease; and
  3. validating biomarkers that predict treatment response.

Find out more

Research Projects

See all
CaverSTIM

World first medical device implantation to restore erectile function
ProstACT

A global study to evaluate investigational radionuclide therapy
Phase 1 Dose Escalation Study of STM-416p

Administered Intraoperatively to Patients Undergoing Radical Prostatectomy
ACT for Erectile Dysfunction

Erectile Dysfunction Adaptation of ACT for Compliance with an Erectile Rehabilitation Program
Tissue Banking

We contribute over 60% of the advanced metastatic prostate cancer samples analysed globally.
Pan Prostate Cancer Group

As part of this global group we analyse genetic data from over 1800 men with prostate cancer.
Genetic Research Program

Identifying different types of prostate cancer and enabling targeted treatment.
Ironman Study

International registry for men with advanced prostate cancer.
Survivorship Research

Identifying different types of prostate cancer and enabling targeted treatment.

Partner with us

Contact our research team at APC to find out how you can partner with us and get involved with our ground-breaking research.

Get in touch